Skip to content
Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), has been included in Washingtonian Magazine’s 2022 list of Washington D.C.’s 500 […]
BIO’s Dr. Michelle McMurry-Heath among DC’s 500 Most Influential People Read More »
The full House Energy & Commerce Committee marked up six health-related bills on May 18, including the reauthorization of the Food and Drug Administration
FDA user fee legislation covers accelerated approval, clinical trial diversity Read More »
Along with funding pandemic preparedness, “U.S. policymakers and lawmakers need to broaden their vision to include preparing for human-generated chemical, biological, radiological, and nuclear
BIO’s View: Russian aggression demands more investment in medical countermeasures Read More »
A new bill with bipartisan support would promote the development and use of biostimulants, which can help farmers and improve the soil by facilitating
Bipartisan bill would boost plant biostimulants Read More »
April marked the 10-year anniversary of the JOBS (Jumpstart Our Business Startups) Act. The bill, which was signed into law thanks to bipartisan support
Looking back on the JOBS Act, 10 years later Read More »
The House Energy & Commerce Health Subcommittee on Wednesday marked up six key bills that address the FDA user fee agreements and some other
FDA user fee agreements advance in House with bipartisan support Read More »
President Biden announced May 4 that the White House will hold a Conference on Hunger, Nutrition, and Health in September, for the first time
White House will host the first food insecurity conference in 50 years Read More »
Pharmacy benefit managers (PBMs) are “part of a broken drug supply chain,” Sen. Richard Blumenthal (D-CT) told a Senate hearing about “Ensuring Fairness and
Senate hearing: PBMs ‘part of a broken drug supply chain’ Read More »
The House Energy & Commerce Committee unveiled on Wednesday “a bipartisan comprehensive legislative package to reauthorize the Food and Drug Administration (FDA) user fee
House unveils package to reauthorize FDA user fee agreements Read More »
The opioid epidemic has hit the United States hard in the last 25 years, killing more than 70,000 in 2019 alone, according to the
FDA draft guidance on non-opioid analgesics ‘inadequate’ Read More »
